TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹4,972 Cr | ₹235 Cr | ₹101 Cr | ₹-142 Cr | ₹-300 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹4,972 Cr |
| Mar2025 | ₹235 Cr |
| Mar2024 | ₹101 Cr |
| Mar2023 | ₹-142 Cr |
| Mar2022 | ₹-300 Cr |
How is Deferred Tax Assets / Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,972 Cr | 2,019.53 | |
| Mar2025 | ₹235 Cr | 132.43 | |
| Mar2024 | ₹101 Cr | Positive | |
| Mar2023 | ₹-142 Cr | Negative | |
| Mar2022 | ₹-300 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹189,249.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
| MANKIND PHARMA | ₹94,050.4 Cr | -1.9% | -5.8% | -12.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 1.3% |
2% |
36.5% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses